According to BASF, Equateq offers unique technology for fatty acid production comprising proprietary chromatographic separation methods.
BASF (Ludwigshafen, Germany) has acquired omega-3 fatty acids manufacturer Equateq Ltd., expanding the BASF portfolio of omega-3 ingredients for the pharmaceutical and dietary supplement markets. Specifically, BASF says Equateq is a supplier of highly concentrated omega-3 fatty acids and will allow BASF to provide new offerings of highly concentrated omega-3 fatty acids.
According to BASF, Equateq offers unique technology for fatty acid production comprising proprietary chromatographic separation methods that allow for a “customized” approach.
“Equateq’s technologies will enable us to customize fatty acid concentrates with variable ratios of EPA and DHA at concentration levels of up to 99% purity. This is unique in the market,” said Martin Widmann, senior vice president, Pharma Ingredients and Services, which is the division in which Equateq will be integrated. The Pharma Ingredients and Services group is part of BASF’s overall Nutrition and Health division.
GC Rieber VivoMega uses AI platform from Intelecy to boost efficiency, quality, and sustainability
August 26th 2024According to the company’s announcement, the AI platform is able to identify real-time deviations or anomalies in GC Rieber VivoMega’s processing facilities and report them via a cloud-based, comprehensive, centralized system.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.